Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LOC100134331///LOC100126583///LOC652128///VSIG6///IGHM///IGHG1///IGHA2///IGHA1///IGH@ |
| Upstream (Parents) |
|---|
| (<<) FOXN1 → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHM///IGHG1///IGHA2///IGHA1///IGH@ |
| (<<) LOC729991-MEF2B → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHM///IGHG1///IGHA2///IGHA1///IGH@ |
| (<<) IGLV2-11///IGLV2-18///IGLV2-23 → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHM///IGHG1///IGHA2///IGHA1///IGH@ |
| (<<) LOC652493 → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHM///IGHG1///IGHA2///IGHA1///IGH@ |
| (<<) LOC652694///IGK@///IGKV1-5///IGKC → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHM///IGHG1///IGHA2///IGHA1///IGH@ |
| (<<) LOC440871///IGK@///IGKV3-20///IGKV3D-11///IGKV3D-15 → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHM///IGHG1///IGHA2///IGHA1///IGH@ |
| (<<) FAM20B → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHM///IGHG1///IGHA2///IGHA1///IGH@ |
| (<<) IGHV@///IGHG1///IGHA1 → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHM///IGHG1///IGHA2///IGHA1///IGH@ |
| Downstream (Children) |
|---|
| LOC100134331///LOC100126583///LOC652128///VSIG6///IGHM///IGHG1///IGHA2///IGHA1///IGH@ → FOXN1 (>>) |
| LOC100134331///LOC100126583///LOC652128///VSIG6///IGHM///IGHG1///IGHA2///IGHA1///IGH@ → LOC729991-MEF2B (>>) |
| LOC100134331///LOC100126583///LOC652128///VSIG6///IGHM///IGHG1///IGHA2///IGHA1///IGH@ → SCN3B (>>) |
| LOC100134331///LOC100126583///LOC652128///VSIG6///IGHM///IGHG1///IGHA2///IGHA1///IGH@ → SMAD6 (>>) |
